Dietary alpha-ketoglutarate supplementation may increase muscle gain through mTOR signaling pathway in diet-induced obese rat

Kang Yao,Xia Xiong,Chenxing Fu,Sudath Dahanayaka,Jian Lei,Wei Lu,Guoyao Wu,Peng Liao,Yulong Yin
2013-01-01
Abstract:Obesity is a major public health crisis worldwide. This study was conducted to test the beneficial effect of α-ketoglutarate (α-KG) in obesity objects. Male Sprague-Dawley rats were fed for 15 wk a high-fat (40% energy) diet beginning at 4 wk of age, resulting in 30% higher body weight gains higher weights in HF than normal fed rats. Starting at 19 wk of age, the rats continued to be fed their diets and receive drinking water containing 0 or 1% α-KG (n = 8 per group) for 10 weeks. Water consumption was measured daily. Food intake and body weights were recorded weekly. At the end of trial, venous blood samples from tail were obtained for metabolite analysis, whereas gastrocnemius muscles were weighed and collected to determine the abundance and phosphorylation state of the mammalian target of the rapamycin (mTOR), ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor (eIF) 4E-binding protein-1 (4E-BP1). In addition, retroperitoneal (RP), epididymal (EP), subcutaneous (SC; inguinal), and mesenteric (MT) fat tissues, as well as brown adipose tissue (located in the interscapular region), brain, kidney, and other tissues were dissected and weighed. The data indicated that 1% α-KG supplementation had no effect on adipose tissue, but increased (P<0.05) gastrocnemius muscle weight compared to control group. Consistent with these data, the addition of 1% α-KG increased (P<0.05) the phosphorylated levels of mTOR and 4E-BP1 proteins. Interestingly, in present study the data showed that α-KG supplementation decreased (P<0.05) the leucine level in plasma. Collectively, our finding may provide new clues for nutritional or pharmacological strategies to treat obese subjects.
What problem does this paper attempt to address?